打印 科室与专家门诊 妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。 有相关专长的科室 妙佑医疗国际的癌症护理 放射科 核医学疗法 核心脏病学实验室 研究此手术的领域 Radiology Research 行此手术的医生 编辑搜索过滤条件 close 缩小搜索范围 根据地点 Rochester, MN 亚利桑那州凤凰城/斯科茨代尔 按姓氏 未找到姓氏以该字母开头的医生 A A 查找姓氏以该字母开头的医生 B B 未找到姓氏以该字母开头的医生 C C 查找姓氏以该字母开头的医生 D D 未找到姓氏以该字母开头的医生 E E 未找到姓氏以该字母开头的医生 F F 查找姓氏以该字母开头的医生 G G 未找到姓氏以该字母开头的医生 H H 未找到姓氏以该字母开头的医生 I I 查找姓氏以该字母开头的医生 J J 查找姓氏以该字母开头的医生 K K 查找姓氏以该字母开头的医生 L L 查找姓氏以该字母开头的医生 M M 查找姓氏以该字母开头的医生 N N 未找到姓氏以该字母开头的医生 O O 查找姓氏以该字母开头的医生 P P 未找到姓氏以该字母开头的医生 Q Q 未找到姓氏以该字母开头的医生 R R 查找姓氏以该字母开头的医生 S S 查找姓氏以该字母开头的医生 T T 未找到姓氏以该字母开头的医生 U U 未找到姓氏以该字母开头的医生 V V 查找姓氏以该字母开头的医生 W W 未找到姓氏以该字母开头的医生 X X 未找到姓氏以该字母开头的医生 Y Y 未找到姓氏以该字母开头的医生 Z Z 重置所有过滤器 搜索提示 给搜索词加引号。 即使搜索栏没有显示自动建议,也请点击“搜索”,您或许仍然可以获得结果。 显示$起始范围 - $结束范围/源自可用$可用医生 Corrie R. Bach, M.D. Radiologist Rochester, MN 擅长领域: Radiopharmaceutical therapy Mike S. Bold, M.D. Radiologist Rochester, MN 擅长领域: Radiopharmaceutical therapy Jolanta M. Durski, M.D. Nuclear Medicine Specialist Rochester, MN 擅长领域: Positron emission tomography scan, Radiopharmaceutical therapy, Thyroid cancer, Pancreatic neuroendocrine tumor, Neuroe...ndocrine tumor 显示更多擅长领域 针对 Jolanta M. Durski, M.D. Ajit H. Goenka, M.D. Radiologist Nuclear Medicine Specialist Rochester, MN 擅长领域: Radiopharmaceutical therapy, Pancreatic neuroendocrine tumor, Neuroendocrine tumor Geoffrey B. Johnson, M.D., Ph.D. Radiologist Nuclear Medicine Specialist Rochester, MN 擅长领域: Radiopharmaceutical therapy, PSMA therapy, Pancreatic neuroendocrine tumor, Neuroendocrine tumor Ayse Tuba Kendi, M.D. Radiologist Rochester, MN 擅长领域: Radiopharmaceutical therapy, PET/CT scan, Pancreatic neuroendocrine tumor, Neuroendocrine tumor Brendan W. Lunn, M.D. Radiologist Nuclear Medicine Specialist Rochester, MN 擅长领域: Radiopharmaceutical therapy Francisco J. Maldonado, M.D. Radiologist Nuclear Medicine Specialist Rochester, MN 擅长领域: Mammogram, Breast MRI, Breast biopsy, SPECT scan, Positron emission tomography scan, Radiopharmaceutical therapy, Contr...ast-enhanced mammogram 显示更多擅长领域 针对 Francisco J. Maldonado, M.D. Julian R. Molina, M.D., Ph.D. Oncologist Rochester, MN 擅长领域: CAR-T cell therapy, Radiopharmaceutical therapy, Lung cancer Patrick J. Navin, M.B., B.Ch., B.A.O. Radiologist Nuclear Medicine Specialist Rochester, MN 擅长领域: MRI, CT scan, SPECT scan, Radiopharmaceutical therapy, Radiation therapy for prostate cancer, PET/MRI scan, PET/CT scan..., Thyroid cancer, Prostate cancer, Neuroendocrine tumor 显示更多擅长领域 针对 Patrick J. Navin, M.B., B.Ch., B.A.O. Pagination 医生搜索 Go to page 11 Go to page 22 NextNext Page 研究妙佑医疗国际的医生和科学家正在研究新型放射性药物,以改进多种疾病和状况的诊断和治疗。 放射性药物疗法是癌症研究的一个活跃领域。这些研究系与妙佑医疗国际综合癌症中心合作开展。美国国家癌症研究所为妙佑医疗国际综合癌症中心提供资助并将其指定为综合癌症中心。这是对该中心在癌症预防、诊断和治疗方面的卓越科学成就和多学科资源的认可。 著述请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际的医生在放射性药物疗法领域的著述目录。 Research Profiles 编辑搜索过滤条件 close 缩小搜索范围 按位置 Arizona Florida Minnesota 观看全部 查看所有医生 • 所有位置 Heath, Elisabeth I. M.D. Minnesota Jain, Manoj K. M.D. Florida Johnson, Geoffrey B. M.D., Ph.D. Minnesota Laack, Nadia N. M.D. Minnesota Pandey, Mukesh K. Ph.D. Minnesota 来自妙佑医疗国际员工 在 Mayo Clinic 治疗 申请预约 关于在 Mayo Clinic 治疗 Dec. 31, 2025 打印显示参考文献 General nuclear medicine. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/gennuclear. Accessed June 25, 2025. What is nuclear medicine and molecular imaging? Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/What-is-Nuclear-Medicine-and-Molecular-Imaging.aspx. Accessed June 25, 2025. About nuclear medicine and molecular imaging. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Web/About/About-Nuclear-Medicine-and-Medical-Imaging. Accessed June 25, 2025. Lapi SE, et al. Recent advances and impending challenges for the radiopharmaceutical sciences in oncology. The Lancet Oncology. 2024; doi:10.1016/S1470-2045(24)00030-5. O'Malley JP, et al., eds. Nuclear Medicine and Molecular Imaging: The Requisites. 5th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed May 13, 2025. Mititelu MR, et al. Overview of adverse reactions of radiopharmaceuticals. Clinical Oncology. 2025; doi:10.1016/j.clon.2025.103857. Bone scan. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/bone-scan. Accessed June 25, 2025. Hepatobiliary nuclear medicine. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/hepatobiliary. Accessed June 25, 2025. Scintimammography. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/scintimammo. Accessed June 25, 2025. Townsend CM Jr, et al. The parathyroid glands. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed July 11, 2025. Pylarify (prescribing information). Progenics Pharmaceuticals; 2023. https://www.pylarify.com. Accessed July 11, 2025. Kit for the preparation of technetium Tc 99m mertiatide injection (prescribing information). Jubilant Radiopharma; 2023. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216820. Accessed July 11, 2025. Fact sheet: Molecular imaging and the brain. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/Molecular-Imaging-and-the-Brain.aspx. Accessed June 25, 2025. Lymphoscintigraphy. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/lympho. Accessed June 25, 2025. Thyroid scan and uptake. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/thyroiduptake. Accessed June 25, 2025. Zevalin (prescribing information). Spectrum Pharmaceuticals; 2018. http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=125019. Accessed July 8, 2025. Lutathera (prescribing information). Novartis; 2024. https://www.lutathera.com. Accessed July 8, 2025. Pluvicto (prescribing information). Novartis; 2025. https://www.pluvicto.com. Accessed July 8, 2025. Metastron (prescribing information). GE Healthcare; 2013. http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020134. Accessed July 8, 2025. Metastron (prescribing information). Bayer; 2019. https://www.xofigo.com. Accessed July 8, 2025. Patient preparation for nuclear medicine procedures involving injections. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Nuclear-Medicine-101.aspx. Accessed June 25, 2025. Renal (kidney) scintigraphy. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/renal. Accessed June 25, 2025. Radioactive iodine (I-131) therapy for hyperthyroidism. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/radioiodine. Accessed June 25, 2025. Hicon (prescribing information). Jubilant Radiopharma; 2021. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021305. Accessed July 8, 2025. Nuclear medicine and radiation safety. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/Fact-Sheet--Nuclear-Medicine-and-Radiation-Safety.aspx. Accessed June 25, 2025. Cardiac nuclear medicine. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/cardinuclear. Accessed June 25, 2025. Health Education & Content Services. Radioactive iodine (I-131). Mayo Clinic; 2018. Health Education & Content Services. Prostate-specific membrane antigen therapy: For the treatment of prostate cancer. Mayo Clinic; 2023. Health Education & Content Services. Radioligand therapy for somatostatin-positive tumors. Mayo Clinic; 2024. Radioimmunotherapy (RIT). RadiologyInfo.org. https://www.radiologyinfo.org/en/info/radio-immuno. Accessed June 25, 2025. Calais J, et al. Best patient care practices for administering PSMA-targeted radiopharmaceutical therapy. Journal of Nuclear Medicine. 2024; doi:10.2967/jnumed.124.268363. All about your radiology report: What to know. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/all-about-your-radiology-report. Accessed July 9, 2025. Catalano OA, ed. Radiopharmaceuticals and contrast agents. In: Clinical PET/MRI. Elsevier; 2023. https://www.clinicalkey.com. Accessed May 13, 2025. Harris KM. Allscripts EPSi. Mayo Clinic. April 23, 2024. Choline C 11 injection (approval letter). New Drug Application 203155. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203155. Accessed April 4, 2025. Become a comprehensive radiopharmaceutical therapy center of excellence. Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Web/Clinical-Practice/Radiopharmaceutical-Therapy-Centers-of-Excellence/Become-a-Comprehensive-Radiopharmaceutical-Therapy-Center-of-Excellence.aspx. Accessed July 29, 2025. Medical review (expert opinion). Mayo Clinic. July 26, 2025. 相关 Metastatic castration-resistant prostate cancer (mCRPC) Prostate cancer recurrence 淋巴瘤 甲亢(甲状腺功能亢进) 甲状腺癌 神经内分泌肿瘤 神经母细胞瘤 类癌瘤 胰腺神经内分泌肿瘤 转移性前列腺癌 4 期 显示更多相关内容 Mayo Clinic 新闻 Radiopharmaceutical therapy shows favorable results for people with tough-to-treat meningioma brain tumors, Mayo Clinic study finds Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer Mayo Clinic uses investigational targeted radiopharmaceutical theranostic for hepatocellular carcinoma in first-in-human clinical trial 放射性药物关于医生与科室在 Mayo Clinic 治疗 PRC-20585722 医学检查与医疗程序 放射性药物